Consistent to this result, we also found the expression of SLC3A2 was elevated in GC tumor tissues, and increased expression SLC3A2 was significantly associated with serosal invasion and marginally associated with lymphonode metastasis in GC patients. The gene discussed is SLC3A2; the disease is gastric cancer.